CORE
đŸ‡ºđŸ‡¦Â
 make metadata, not war
Services
Services overview
Explore all CORE services
Access to raw data
API
Dataset
FastSync
Content discovery
Recommender
Discovery
OAI identifiers
OAI Resolver
Managing content
Dashboard
Bespoke contracts
Consultancy services
Support us
Support us
Membership
Sponsorship
Community governance
Advisory Board
Board of supporters
Research network
About
About us
Our mission
Team
Blog
FAQs
Contact us
Filters
3 research outputs found
Oxaliplatin (OXA) with weekly bolus 5-fluorouracil (FU) and low-dose leucovorin (ld-LV) in advanced colorectal cancer (ACRC) patients (pts): Report of safety and efficacy
Author
A. Guercovich
C. Coronado
+8Â more
E. Roca
E. Wasserman
G. Giornelli
J. Ă–connor
M. Barugel
M. Chacon
R. Chacon
S. Carraro
Publication venue
'American Society of Clinical Oncology (ASCO)'
Publication date
Field of study
No full text
Crossref
Oxaliplatin (OXA) with weekly bolus 5-fluorouracil (FU) and low-dose leucovorin (ld-LV) in advanced colorectal cancer (ACRC) patients (pts): Report of safety and efficacy
Author
A. Guercovich
C. Coronado
+8Â more
E. Roca
E. Wasserman
G. Giornelli
J. Ă–connor
M. Barugel
M. Chacon
R. Chacon
S. Carraro
Publication venue
'American Society of Clinical Oncology (ASCO)'
Publication date
Field of study
No full text
Crossref
Breast cancer in Latin America: Experts perceptions compared with medical care standards
Author
A. Buzaid
A. Guercovich
+20Â more
Anderson
Anderson
Baquet
C. Garbino
C. Vallejos
Carlson
Cazap
E. Cazap
F. Orlandi
Ferlay
G. Breitbart
G. Schwartsmann
Gottret
IARC Working Group on the Evaluation of Cancer-Preventive Strategies
J. de la Garza
Menke
Olopade
Pisani
Schwartsmann
World Health Organization (WHO)
Publication venue
'Elsevier BV'
Publication date
Field of study
No full text
Crossref